Table 5.
The ORs and 95% CI of inflammatory indicators to AS by logistic regression.
Model 1 | Model 2 | |||||
---|---|---|---|---|---|---|
OR | 95% CI | p | OR | 95% CI | P | |
LYa | 0.52 | 0.40–0.67 | 0.041 | 0.93 | 0.71–1.20 | 0.572 |
NEa | 1.20 | 1.09–1.33 | <0.001 | 1.16 | 1.02–1.32 | 0.025 |
MOa | 11.57 | 5.20–26.64 | <0.001 | 5.87 | 2.17–15.64 | <0.001 |
PLTa | 1.00 | 0.99–1.00 | 0.023 | 1.00 | 1.00–1.00 | 0.241 |
NLRa | 1.63 | 1.43–1.87 | <0.001 | 1.22 | 1.04–1.44 | 0.018 |
MLRa | 494.21 | 137.74–1,884.73 | <0.001 | 13.43 | 3.00–64.07 | <0.001 |
PLRa | 1.01 | 1.00–1.01 | <0.001 | 1.00 | 1.00–1.00 | 0.106 |
LYb | 0.39 | 0.28–0.53 | <0.001 | 0.87 | 0.63–1.18 | 0.389 |
NEb | 1.21 | 1.08–1.36 | 0.001 | 1.30 | 1.11–1.52 | 0.001 |
MOb | 12.38 | 4.67–33.92 | <0.001 | 12.44 | 3.53–47.30 | <0.001 |
PLTb | 1.00 | 0.99–1.00 | 0.058 | 1.00 | 1.00–1.00 | 0.093 |
NLRb | 1.80 | 1.53–2.13 | <0.001 | 1.35 | 1.10–1.66 | 0.004 |
MLRb | 897.37 | 192.70–4,562.99 | <0.001 | 28.95 | 5.04–184.79 | <0.001 |
PLRb | 1.01 | 1.01–1.01 | <0.001 | 1.00 | 1.00–1.01 | 0.038 |
LYc | 0.02 | 0.66–1.49 | 0.923 | 1.21 | 0.68–2.34 | 0.546 |
NEc | 1.14 | 0.99–1.36 | 0.092 | 1.03 | 0.87–1.20 | 0.716 |
MOc | 6.95 | 1.95–30.69 | 0.006 | 2.11 | 0.30–12.12 | 0.441 |
PLTc | 1.00 | 0.99–1.00 | 0.516 | 1.00 | 1.00–1.00 | 0.909 |
NLRc | 1.29 | 1.04–1.63 | 0.023 | 1.02 | 0.76–1.33 | 0.889 |
MLRc | 71.69 | 7.47–827.64 | <0.001 | 1.30 | 0.07–34.09 | 0.867 |
PLRc | 1.00 | 1.00–1.01 | 0.631 | 1.00 | 0.99–1.00 | 0.759 |
Model 1: Uanadjusted.
Model 2: Adjusted for age, sex, BMI, HTN, DM, alcohol, smoke, LDL-C, UA, TGs, FBG, and CHOL.
In all participants.
In men.
In women.
OR, odds ratio; CI, confidence interval; BMI, body mass index; HTN, hypertension; DM, diabetes; LDL-C, low-density lipoprotein; UA, uric acid; TGs, triglycerides; FBG, fasting blood glucose; CHOL, cholesterol; LY, lymphocyte; NE, neutrophil; MO, monocyte; PLT, platelet; NLR, neutrophil–lymphocyte ratio; MLR, monocyte–lymphocyte ratio; PLR, platelet–lymphocyte ratio.